View in EDS HTML Full Text PDF Full Text

RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia.

Saved in:
Bibliographic Details
Title: RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia.
Authors: Vicente-Garcés C; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain., Fernández G; Department of Genetic and Molecular Medicine-IPER, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Esperanza-Cebollada E; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain., Richarte-Franqués M; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain., Crespo-Carrasco A; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain., Montesdeoca S; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Barcelona, Spain., Isola I; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Barcelona, Spain., Sarrate E; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Barcelona, Spain., Cuatrecasas E; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.; Department of Genetic and Molecular Medicine-IPER, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Rives S; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Leukemia and Lymphoma Department. Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu Barcelona, Barcelona, Spain., Dapena JL; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.; Leukemia and Lymphoma Department. Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu Barcelona, Barcelona, Spain., Camós M; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Barcelona, Spain., Vega-García N; Developmental Tumors Biology Group, Leukaemia and Paediatric Haematology Disorders, Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Hospital Sant Joan de Déu (IRSJD), Esplugues de Llobregat, Barcelona, Spain.; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Esplugues de Llobregat, Barcelona, Spain.
Source: British journal of haematology [Br J Haematol] 2025 May; Vol. 206 (5), pp. 1355-1365. Date of Electronic Publication: 2025 Mar 30.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2141
DOI:10.1111/bjh.20056